HQL News and Press, TeklaLife Sciences Investors From 05/04/19

For income investors, closed-end funds, or CEFs, are an attractive class of asset that promises high income generally in the range of 6%-10%, broad diversification in terms of types of assets, and market matching total returns in the long term, if selected carefully. However, CEFs come with ...

By Marshall Gordon and Nicholas Wu, PhD Healthcare stocks normally react to political rhetoric, but the speed and magnitude of the recent correction in the sector have been surprising. Despite bipartisan clamoring for broad changes to the healthcare system and the Trump administration'...

This article was first released to CEF/ETF Income Laboratory subscribers 2 weeks ago, so data may be out of date. Please check latest data before making investment decisions. The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movem...

This article was first released to CEF/ETF Income Laboratory subscribers 2 weeks ago, so data may be out of date. Please check latest data before making investment decisions. The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movem...

A few days ago, I published an article to this site discussing one of the better biotechnology funds, which is an area of the economy that could quite easily have a very bright future. However, the entire healthcare industry itself is likely to prove quite promising due to certain conditions...

This article was first released to CEF/ETF Income Laboratory subscribers two weeks ago, so data may be out of date. Please check latest data before making investment decisions. The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movement...

Earlier today, I encountered an article discussing how scientists have managed to use electrostatic therapy to improve a person's memory and cognitive function. This treatment could have major applications in the treatment of conditions such as Alzheimer's and the researchers intend to devel...

This article was first released to subscribers 1 month ago. Quantitative screens help to rapidly narrow down attractive candidates from the database of 500-plus closed-end funds [CEFs] for further due diligence and investigation. Previous editions of the Report can be searched using the ke...

This article was first released to CEF/ETF Income Laboratory subscribers two weeks ago. The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movements in closed-end fund ((CEF)) sectors in the last week, as well as to highlight recently c...

Tekla Life Sciences Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-y...